2024 surveillance of familial hypercholesterolaemia (NICE guideline CG71)
Prioritisation board agreed there was sufficient evidence to support recommendation development. Updated guidance should improve patient outcomes.
Review decision: Prioritised
We plan to update the recommendations on case finding and diagnosis.
This page was last updated: